메뉴 건너뛰기




Volumn 53, Issue 11, 2010, Pages 957-964

Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia

Author keywords

Acute; Childhood; Flow cytometry; Lymphoblastic leukemia; Minimal residual disease

Indexed keywords


EID: 79951804790     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2010.53.11.957     Document Type: Article
Times cited : (11)

References (25)
  • 1
    • 40749150603 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia
    • Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-43.
    • (2008) Lancet , vol.371 , pp. 1030-1043
    • Pui, C.H.1    Robison, L.L.2    Look, A.T.3
  • 2
    • 47049093795 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study
    • Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008;111:5477-85.
    • (2008) Blood , vol.111 , pp. 5477-5485
    • Borowitz, M.J.1    Devidas, M.2    Hunger, S.P.3    Bowman, W.P.4    Carroll, A.J.5    Carroll, W.L.6
  • 3
    • 0032572924 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-- Childhood Leukemia Cooperative Group
    • Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-- Childhood Leukemia Cooperative Group. N Engl J Med 1998;339:591-8.
    • (1998) N Engl J Med , vol.339 , pp. 591-598
    • Cave, H.1    van der ten Werff Bosch, J.2    Suciu, S.3    Guidal, C.4    Waterkeyn, C.5    Otten, J.6
  • 4
    • 0034667685 scopus 로고    scopus 로고
    • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
    • Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96:2691-6.
    • (2000) Blood , vol.96 , pp. 2691-2696
    • Coustan-Smith, E.1    Sancho, J.2    Hancock, M.L.3    Boyett, J.M.4    Behm, F.G.5    Raimondi, S.C.6
  • 6
    • 77954727839 scopus 로고    scopus 로고
    • Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia
    • Stow P, Key L, Cjen X, Pan Q, Neale GA, Coustan-Smith E, et al. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. Blood 2010;115:4657-63.
    • (2010) Blood , vol.115 , pp. 4657-4663
    • Stow, P.1    Key, L.2    Cjen, X.3    Pan, Q.4    Neale, G.A.5    Coustan-Smith, E.6
  • 7
    • 77951441599 scopus 로고    scopus 로고
    • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study
    • Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010;115:3206-14.
    • (2010) Blood , vol.115 , pp. 3206-3214
    • Conter, V.1    Bartram, C.R.2    Valsecchi, M.G.3    Schrauder, A.4    Panzer-Grumayer, R.5    Moricke, A.6
  • 9
    • 0038268132 scopus 로고    scopus 로고
    • Determination of minimal residual disease in leukaemia patients
    • Campana D. Determination of minimal residual disease in leukaemia patients. Br J Haematol 2003;121:823-38.
    • (2003) Br J Haematol , vol.121 , pp. 823-838
    • Campana, D.1
  • 10
    • 33744800549 scopus 로고    scopus 로고
    • Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia
    • Scrideli CA, de Paula Queiroz R, Bernardes JE, Defavery R, Valera ET, Tone LG. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia. Leuk Res 2006;30:1049-52.
    • (2006) Leuk Res , vol.30 , pp. 1049-1052
    • Scrideli, C.A.1    de Paula Queiroz, R.2    Bernardes, J.E.3    Defavery, R.4    Valera, E.T.5    Tone, L.G.6
  • 11
    • 66749132483 scopus 로고    scopus 로고
    • A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups
    • Scrideli CA, Assumpcao JG, Ganazza MA, Araujo M, Toledo SR, Lee ML, et al. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica 2009;94:781-9.
    • (2009) Haematologica , vol.94 , pp. 781-789
    • Scrideli, C.A.1    Assumpcao, J.G.2    Ganazza, M.A.3    Araujo, M.4    Toledo, S.R.5    Lee, M.L.6
  • 12
    • 33745622137 scopus 로고    scopus 로고
    • A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome
    • Coustan-Smith E, Ribeiro RC, Stow P, Zhou Y, Pui CH, Rivera GK, et al. A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood 2006;108:97-102.
    • (2006) Blood , vol.108 , pp. 97-102
    • Coustan-Smith, E.1    Ribeiro, R.C.2    Stow, P.3    Zhou, Y.4    Pui, C.H.5    Rivera, G.K.6
  • 13
    • 76749095066 scopus 로고    scopus 로고
    • Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report
    • Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, et al. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 2010;24:285-97.
    • (2010) Leukemia , vol.24 , pp. 285-297
    • Gaynon, P.S.1    Angiolillo, A.L.2    Carroll, W.L.3    Nachman, J.B.4    Trigg, M.E.5    Sather, H.N.6
  • 14
    • 0842301453 scopus 로고    scopus 로고
    • Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry
    • McKenna RW, Asplund SL, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma 2004;45:277-85.
    • (2004) Leuk Lymphoma , vol.45 , pp. 277-285
    • McKenna, R.W.1    Asplund, S.L.2    Kroft, S.H.3
  • 15
    • 0035137567 scopus 로고    scopus 로고
    • Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome
    • Ito S, Ishida Y, Murai K, Kuriya S. Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome. Leuk Res 2001;25:205-11.
    • (2001) Leuk Res , vol.25 , pp. 205-211
    • Ito, S.1    Ishida, Y.2    Murai, K.3    Kuriya, S.4
  • 16
    • 57549106619 scopus 로고    scopus 로고
    • Minimal residual disease in acute lymphoblastic leukemia
    • Campana D. Minimal residual disease in acute lymphoblastic leukemia. Semin Hematol 2009;46:100-6.
    • (2009) Semin Hematol , vol.46 , pp. 100-106
    • Campana, D.1
  • 17
    • 70449711125 scopus 로고    scopus 로고
    • Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow
    • Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, et al. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol 2009;27:5168-74.
    • (2009) J Clin Oncol , vol.27 , pp. 5168-5174
    • Basso, G.1    Veltroni, M.2    Valsecchi, M.G.3    Dworzak, M.N.4    Ratei, R.5    Silvestri, D.6
  • 18
    • 0034054159 scopus 로고    scopus 로고
    • New definition of remission in childhood acute lymphoblastic leukemia
    • Pui CH, Campana D. New definition of remission in childhood acute lymphoblastic leukemia. Leukemia 2000;14:783-5.
    • (2000) Leukemia , vol.14 , pp. 783-785
    • Pui, C.H.1    Campana, D.2
  • 19
    • 15244340145 scopus 로고    scopus 로고
    • Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology
    • Cazzaniga G, Biondi A. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Haematologica 2005;90:382-90.
    • (2005) Haematologica , vol.90 , pp. 382-390
    • Cazzaniga, G.1    Biondi, A.2
  • 20
    • 0036660158 scopus 로고    scopus 로고
    • Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood lymphoblastic leukemia
    • Coustan-Smith E, Sancho J, Behm FG, Hancock ML, Razzouk BI, Ribeiro RC, et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood lymphoblastic leukemia. Blood 2002;100:52-8.
    • (2002) Blood , vol.100 , pp. 52-58
    • Coustan-Smith, E.1    Sancho, J.2    Behm, F.G.3    Hancock, M.L.4    Razzouk, B.I.5    Ribeiro, R.C.6
  • 21
    • 0032770146 scopus 로고    scopus 로고
    • Detection of minimal residual disease in acute leukemia by flow cytometry
    • Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999;38:139-52.
    • (1999) Cytometry , vol.38 , pp. 139-152
    • Campana, D.1    Coustan-Smith, E.2
  • 23
    • 84895911558 scopus 로고    scopus 로고
    • Detection of minimal residual disease by IgH gene rearragnement-PCR in childhood acute lymphoblastic leukemia
    • Park CJ, Kim MC, Moon AR, Seo EJ, Chi HS, Seo JJ, et al. Detection of minimal residual disease by IgH gene rearragnement-PCR in childhood acute lymphoblastic leukemia. Korean J Clin Pathol 1999;19:163-71.
    • (1999) Korean J Clin Pathol , vol.19 , pp. 163-171
    • Park, C.J.1    Kim, M.C.2    Moon, A.R.3    Seo, E.J.4    Chi, H.S.5    Seo, J.J.6
  • 24
    • 77955981974 scopus 로고    scopus 로고
    • Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia
    • Cui L, Li Z, Wu M, Li W, Gao C, Deng G. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia. Leuk Res 2010;34:1314-9.
    • (2010) Leuk Res , vol.34 , pp. 1314-1319
    • Cui, L.1    Li, Z.2    Wu, M.3    Li, W.4    Gao, C.5    Deng, G.6
  • 25
    • 67650478894 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
    • Sutton R, Venn NC, Tolisano J, Bahar AY, Giles JE, Ashton LJ, et al. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. Br J Haematol 2009;146:292-9.
    • (2009) Br J Haematol , vol.146 , pp. 292-299
    • Sutton, R.1    Venn, N.C.2    Tolisano, J.3    Bahar, A.Y.4    Giles, J.E.5    Ashton, L.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.